Aug 3, 2026 07:09AM

Jun 16, 2026 08:01AM

Jun 15, 2026 06:05AM

Apr 29, 2026 09:08AM

Apr 27, 2026 08:47AM

Feb 23, 2026 08:31AM

Dec 12, 2025 04:17PM Adial Pharmaceuticals (ADIL) files for 13.82M share offering by selling stockholders

Nov 26, 2025 08:01AM

Nov 14, 2025 04:25PM

Oct 9, 2025 08:32AM

Sep 30, 2025 07:38AM

Sep 3, 2025 08:30AM

Aug 20, 2025 08:31AM

Aug 6, 2025 08:02AM Adial Pharmaceuticals completes FDA meeting for AD04 phase 3 trial

Jul 9, 2025 08:32AM

Jun 25, 2025 08:35AM

Jun 17, 2025 08:02AM

Jun 11, 2025 08:01AM

May 30, 2025 04:14PM

May 8, 2025 08:30AM

May 2, 2025 11:49AM Adial Pharmaceuticals (ADIL) Announces a Warrant Inducement Transaction for $2.75 Million in Gross Proceeds

May 1, 2025 08:32AM

Mar 4, 2025 09:59AM

Feb 25, 2025 09:01AM

Feb 19, 2025 09:02AM

Feb 12, 2025 09:01AM

Jan 29, 2025 09:02AM

Dec 3, 2024 08:31AM Adial Pharmaceuticals (ADIL) Granted Key U.S. Patent for the Treatment of Alcohol and Drug Dependence Based on Expanded Genotype Combinations

Nov 14, 2024 08:40AM

Nov 14, 2024 06:38AM

Nov 5, 2024 08:30AM

Oct 17, 2024 09:03AM

Sep 19, 2024 08:31AM

Aug 13, 2024 09:03AM

Jul 31, 2024 08:32AM Adial Pharmaceuticals (ADIL) Files New Patent Application to Protect Core Assets and Extend IP Exclusivity on Core Technology to 2044

456,379 total articles have been posted to this entity.

Click Here to Sign-Up for StreetInsider.com Premium to View All